TODD GREGORY TOLBERT, M.D.

Plain English
This study focused on a new treatment for Multiple Sclerosis (MS), an autoimmune disease that harms the nerves. Scientists created a modified version of a peptide that helps target the immune system’s T cells to protect myelin, the protective covering of nerves, and found that this new form, called MBP-Fc-BPI, works better and lasts longer in the body compared to older versions. Specifically, MBP-Fc-BPI not only reduced disease symptoms more effectively but also has a longer lifespan in the body, minimizing the need for higher doses that could cause side effects. Who this helps: This helps patients with MS by offering a more effective treatment option with fewer risks.

Plain English
The researchers studied how exposing a type of antibody called IgG4-Fc to UV light affects its structure and stability, focusing on certain amino acids that can break down. They found that mutations in these amino acids led to a significant loss of thermal stability—up to a 10-fold decrease in binding strength to receptors—and changes in how the antibody behaves under light exposure. This is important because understanding these effects can help improve the stability and effectiveness of antibody therapies. Who this helps: This helps patients who rely on antibody treatments for their health conditions.

Plain English
The study focused on adapting a program called Stop the Bleed (STB), which teaches important techniques for controlling bleeding, for deaf and hard-of-hearing (DHH) individuals. After modifying the program with the help of experts, they conducted a training session with 18 DHH high school students. Results showed that after the training, 67% of participants felt confident in their ability to stop severe bleeding, a significant increase from 27% before the training, highlighting that the program could effectively reach and empower this underserved community. Who this helps: This benefits deaf and hard-of-hearing patients by providing them access to life-saving training.

Plain English
This study examined how exposure to UV and visible light affects the stability of different therapeutic proteins called IgG1-based modalities. Researchers found that the NISTmAb and Flt-3L-Ig proteins were more likely to break down when exposed to light compared to a high mannose Fc fragment, with specific breakdown happening at certain points in the protein structure. This matters because ensuring the stability of these proteins is crucial for developing effective and safe medications. Who this helps: This helps patients who rely on these therapeutic proteins for treatment.

Plain English
This research focused on creating a new treatment called MOG-Fc-BPI to help tackle primary progressive multiple sclerosis (PPMS) in mice. The study found that mice treated with MOG-Fc-BPI showed no signs of the disease after treatment, while the untreated mice lost significant weight and experienced symptoms. This matters because it indicates that MOG-Fc-BPI could be a promising new therapy for people with PPMS, providing a potential alternative to the currently limited options available. Who this helps: Patients with primary progressive multiple sclerosis.

Plain English
This study looked at how the time of day affects balance and stability in athletes and non-athletes, as measured by two specific tests. Researchers found that while the time of day didn't significantly changebalance results, athletes performed better overall than non-athletes. This matters because understanding how time of day impacts balance assessments can lead to more accurate decisions about when athletes can safely return to activity after an injury. Who this helps: This helps athletes and healthcare providers making return-to-play decisions.

Plain English
This research focuses on new treatments for multiple sclerosis (MS), an autoimmune disease where the immune system mistakenly attacks the body. The study examines various methods using antigenic peptides—the parts of the target proteins that trigger the immune response—to specifically target and manage the harmful immune cells involved in MS, without weakening the overall immune system. The goal is to reduce inflammation and damage to the body while minimizing side effects seen with traditional treatments that suppress the immune response. Who this helps: This helps patients with multiple sclerosis by offering more targeted and potentially safer treatment options.

Plain English
This study looked at 11 patients with severe COVID-19 who needed help breathing with machines. It found that higher heart output, measured by cardiac index, was linked to poorer oxygen levels in the blood. Improving heart output may help these patients breathe better and get more oxygen. Who this helps: This benefits patients with severe COVID-19 and their doctors.

Plain English
This study looked at different versions of an antibody called IgG4-Fc to see how their sugar structures affect their stability and ability to bind to a specific receptor. The researchers found that versions of IgG4-Fc with different sugars showed varying levels of stability and binding strength, with some forms binding to the receptor 14.7 times better than a certain type without sugars. This is important because understanding how these different forms work can help improve antibody treatments for diseases. Who this helps: Patients receiving antibody-based therapies.

Plain English
This study examined critically ill COVID-19 patients who experienced severe lung issues and showed signs of blood clots in the lungs. The researchers treated four patients with a medication called tPA, which helps dissolve blood clots, and all four had immediate improvements in their breathing and overall blood flow. This is important because it suggests that treating COVID-19 pneumonia with this approach might enhance outcomes for patients suffering from severe lung complications. Who this helps: This helps critically ill COVID-19 patients by providing a potential new treatment option.

Plain English
The researchers studied patients with severe COVID-19 and found that their respiratory issues were likely caused by tiny blood clots in the lungs and problems with the lung's blood vessels. In five patients treated with a drug called tPA, which breaks up blood clots, there were immediate improvements in their breathing and blood flow. This suggests that treating severe COVID-19 pneumonia may require blood thinners for milder cases and clot-busting drugs for those in worse condition. Who this helps: This helps critically ill COVID-19 patients and their doctors.

Plain English
This study looked at how the angle at which 3D-printed models are made affects their surface texture. Researchers created 48 dental models using different angles—0 degrees, 30 degrees, and 70 degrees—and found that the angle significantly impacted how rough the surfaces were, with results varying based on the materials used. This matters because smoother surfaces can lead to better fitting dental applications and improved patient comfort. Who this helps: This helps patients who need dental models for procedures.

Plain English
This study looked at a protein called enhancer of zeste homolog 2 (EZH2) to see how it affects acute kidney injury (AKI). Researchers found that blocking EZH2 helped protect kidney cells by preventing damage and maintaining important cell junctions, which are crucial for kidney function. Specifically, treatment with a drug reduced kidney damage and preserved vital proteins, suggesting that targeting EZH2 could be an effective way to prevent or lessen AKI. Who this helps: This helps patients at risk for acute kidney injury, including those undergoing surgery or receiving certain medications.

Plain English
This paper looks at unusual types of pneumonia, specifically caused by bacteria like Legionella, Chlamydophila, and Mycoplasma. It highlights that these atypical pneumonia cases can be hard to diagnose, which may lead to them being treated less effectively than they should be. Understanding these bacteria better could improve patient care and reduce hospital stays and deaths from pneumonia. Who this helps: Patients suffering from pneumonia, especially those with atypical cases.

Plain English
This study investigated four different forms of a protein called IgG1-Fc to understand how they break down chemically under harsh conditions. The researchers found that specific parts of these proteins, notably Asn315 and Trp277, showed signs of degradation, with significant changes occurring when the proteins were tested over three months at high temperatures. This is important because understanding these differences can help ensure that similar medicines (biosimilars) are safe and effective, which affects how these drugs are developed and monitored. Who this helps: This helps patients who rely on safe and effective treatments derived from protein therapies.

Plain English
This study looked at a baby born with a condition called campomelic dysplasia, which is a serious skeletal disorder that causes bent limbs and a misshapen chest. The researchers noted that the baby showed signs of this condition before birth, indicating a high risk of severe health problems. Unfortunately, the newborn's health quickly declined after delivery. Who this helps: This helps doctors and families understand the risks associated with campomelic dysplasia during pregnancy and after birth.

Plain English
This study looked at how estrogen affects heart and blood vessel health, especially in women after menopause. Researchers found that estrogen can help prevent certain types of cell growth in blood vessels after injury, which could reduce the risk of heart disease. Their findings indicate that estrogen may block processes that lead to problems in blood vessels, but more research is needed to understand how it could help women with heart conditions. Who this helps: This helps women going through menopause and healthcare providers treating them.

Plain English
This study looked at how estrogen affects blood vessel repair after injury in mice, specifically whether its protective effects rely on a protein called inducible nitric oxide synthase (iNOS). The researchers found that female mice had significantly less new blood vessel formation after injury compared to males—over 90% less in those with iNOS and 65% less in those without it. Importantly, even when iNOS was not present, estrogen still helped protect the blood vessels, showing that its benefits do not solely depend on this protein. Who this helps: This helps patients, especially women, by providing insights into how estrogen may protect against vascular injuries.